Back to Search
MOTHAFFAR RIMAWI, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1245241843IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
M0338(TX)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
M0338(TX)
Education
OTHER
Class of 1997
Research & Publications (4)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.
PMID 18245484·Cancer Res·2008
7-preclinical
Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.
PMID 17470737·J Natl Cancer Inst·2007
7-preclinical
Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancer.
PMID 16912207·Cancer Res·2006
7-preclinical
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
PMID 16273359·Cancer Chemother Pharmacol·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1504 TAUB LOOP
HOUSTON, TX 77030 - Phone
- (713) 873-8890
Quick Facts
- NPI
- 1245241843
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 29
- Publications
- 4
Are you this provider?
Claim Your Profile